seekingalpha.com
/2 weeks ago
Latest updates for Tvlrx
Fresh curated links around TVLRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Telix Pharmaceuticals Limited (TLX) Discusses Neurologic Oncology Portfolio and Advances in Therapeutic and Diagnostic A
- Travere Therapeutics, Inc. (TVTX) Discusses Exclusive Licensing and Collaboration Agreement for Seborbrutinib with Evere
- Is Travere Therapeutics, Inc. (TVTX) A Good Stock To Buy Now?
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/1 month ago
Travere Therapeutics, Inc. (TVTX) Discusses Exclusive Licensing and Collaboration Agreement for Seborbrutinib with Evere...
finance.yahoo.com
/1 month ago
Is Travere Therapeutics, Inc. (TVTX) A Good Stock To Buy Now?
cantechletter.com
/6 days ago
Buy Lantronix for a double, this analyst says
Roth Capital Partners analyst Scott Searle says Lantronix’s (Lantronix Stock Quote, Chart, News, Analysts, Financials NASDAQ:LTRX) acquisition of Vecima Networks’ industrial IoT pl...
seekingalpha.com
/1 week ago
Travere Therapeutics: Filspari Is Becoming A Rare Kidney Disease Platform
finance.yahoo.com
/3 weeks ago
Here’s why Lantronix, Inc. (LTRX) is an Underappreciated High Growth Micro-Cap Stock to Buy Now
seekingalpha.com
/1 month ago
Terveystalo Oyj (TTALF) Terveystalo Oyj, - M&A Call - Slideshow
cantechletter.com
/1 month ago
Is Theralase Technologies a buy?
Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$0.70 target on Theralase Technologies (Theralase Technologies Stock Quote, Chart, News, Analysts, F...
fiercehealthcare.com
/1 week ago
Lenz Therapeutics rolls out telehealth offering for Vizz prescription eye drops
A patient-driven telehealth Rx model is more sustainable given the success of other aesthetic Rx products offered via telehealth, including GLP-1s and acne medications, Leerink Par...
seekingalpha.com
/1 month ago
Elevra Lithium Limited (ELVR) Presents at ASX CEO Connect June 2026 - Slideshow
seekingalpha.com
/14 hours ago
Elevance Health, Inc. (ELV) Q2 2026 Earnings Call Transcript
seekingalpha.com
/2 weeks ago
Liftoff Mobile: Advantage In Data And Access To Both Demand And Supply Side
fool.com
/3 days ago
LQD vs TLT: How Do These Two Popular Fixed Income ETFs Compare?
Both BlackRock ETFs offer identical 4.6% yields, but LQD delivered 4.2% returns over 12 months versus TLT's 2.5%, with significantly lower volatility.
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Tvlrx
seekingalpha.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
cantechletter.com
Recent coverage from public sources
Public source
fiercehealthcare.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source